If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDuke Capital Regulatory News (DUKE)

Share Price Information for Duke Capital (DUKE)

Share Price is delayed by 15 minutes
Get Live Data
25.75    0.00 (0.00%)
Bid:
25.50
Ask:
26.00
Spread: 0.50 (1.961%)
Market Cap: £130.91m
DUKE Live PriceLast checked at - London Stock Exchange

Intraday Duke Capital Share Chart

Trading and Operational Update

31 Mar 2025 07:00

RNS Number : 7681C
Duke Capital Limited
31 March 2025
 

31 March 2025

Duke Capital Limited

 

("Duke Capital", "Duke" or the "Company")

 

Trading and Operational Update

 

Duke Capital Limited (AIM: DUKE), a leading provider of hybrid capital solutions for SME business owners in Europe and North America, is pleased to provide guidance on its trading for the fourth quarter of the financial year ending 31 March 2025 ("Q4 FY25").

 

Trading Update

 

Based on current trading, Duke expects to achieve recurring cash revenue* of £6.5 million in Q4 FY25. This represents a 12% year-on-year increase on Q4 FY24 (£5.8 million) and equal to the prior quarter, Q3 FY25, which saw the Company deliver recurring cash revenue of £6.5 million.

 

Overview of quarterly revenue growth:

 

 

Recurring Cash Revenue*

Total Cash Revenue**

Q3 FY24

£6.3 million

£6.3 million

Q4 FY24

£5.8 million

£10.2 million

Q1 FY25

£6.3 million

£6.8 million

Q2 FY25

£6.4 million

£6.8 million

Q3 FY25

£6.5 million

£6.5 million

 

* Recurring cash revenue excludes exit premium receipts and cash gains from equity sales

** Total cash revenue is monthly cash distributions from Duke's partners plus exit premium receipts and cash gains from equity sales

 

 

Operational Update

 

In February, Duke completed a £1.9 million follow-on investment into BPVA (Ireland) Limited to facilitate the acquisition of Pinta Crew Limited, an Irish consultancy business specialising in helping Irish and international organisations optimise their people, processes and resources.

 

Neil Johnson, CEO of Duke Capital, said:

 

"Despite the UK's stickier inflationary pressures, we are pleased to report that we are on track to achieve a solid year-on-year increase in recurring cash revenues for Q4 FY25. This performance reflects the strength of our business model in navigating challenging market conditions, while our follow-on investment in BPVA underscores our commitment to supporting our portfolio. With a strong balance sheet, we are confident we can deliver long-term, sustainable value for shareholders."

 

***ENDS***

 

For further information, please visit https://dukecapital.com/ or contact:

 

Duke Capital Limited

Neil Johnson / Charles Cannon Brookes / Hugo Evans

 

+44 (0) 1481 231 816

Cavendish Capital Markets Limited (Nominated Adviser and Joint Broker)

Stephen Keys / Callum Davidson / Michael Johnson 

+44 (0) 207 220 0500

 

Canaccord Genuity Limited

(Joint Broker)

 

Adam James / Harry Rees

+44 (0) 207 523 8000

SEC Newgate (Financial Communications)

Robin Tozer / Alice Cho / Olivia Hart

+ +44 (0) 20 3757 6882 dukecapital@secnewgate.co.uk

 

 

About Duke Capital

 

Duke is a leading provider of hybrid capital solutions for SME business owners in Europe and North America, combining the best features of both equity and debt.

 

Since 2017, Duke has provided unique long-term financing which eliminates re-financing risk and necessity for a short-term exit by providing a unique 'corporate mortgage' while also aligning its returns to grow with the success of the business.

 

Duke is focused on generating attractive risk-adjusted returns for shareholders and has a track record of achieving this across market cycles. It's three investment pillars are capital preservation, attractive dividend yield, and to provide upside upon exits.

 

Duke is listed on the AIM market under the ticker DUKE and is headquartered in Guernsey.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTPKFBQABKDNNB
Date   Source Headline
4th Feb 20197:00 amRNSAcquisition of UK royalty finance provider
17th Dec 20187:00 amRNSFollow-on contribution to royalty partner
5th Dec 20187:00 amRNSIssue of Shares and Total Voting Rights
4th Dec 20187:00 amRNSInterim results and dividend declaration
27th Nov 201811:31 amRNSDuke Royalty to Present at Mello London
31st Oct 20187:00 amRNSLTIP Awards and other Issuances
30th Oct 20187:00 amRNSOperational and Corporate Update
28th Sep 20187:00 amRNSFurther Contribution to Royalty Partner
24th Sep 20187:00 amRNSFinal Results and Notice of AGM
20th Sep 20187:00 amRNSDividend Declaration and Notice of Results
30th Aug 20187:00 amRNSNew Royalty Agreement
6th Aug 20184:50 pmRNSNotification of major holdings
6th Aug 20184:45 pmRNSNotification of major holdings
6th Aug 20183:18 pmRNSHolding(s) in Company
6th Aug 20181:18 pmRNSNotification of Major Holdings
2nd Aug 201812:20 pmRNSResult of EGM and Issue of Equity
16th Jul 20187:00 amRNSFundraising to raise £44m and EGM announcement
13th Jul 20184:56 pmRNSFundraising to raise £44 million and notice of EGM
19th Jun 20187:00 amRNSInterim Dividend Increase
14th Jun 20187:01 amRNSRoyalty finance agreement LOI and secured loan
14th Jun 20187:00 amRNSUpdate on Exclusive Collaboration
8th May 20187:00 amRNSOperational Update on Royalty Partners
26th Apr 20187:00 amRNSFurther Contribution to Royalty Partner
24th Apr 20187:00 amRNSNew Royalty Agreement
16th Apr 20181:34 pmRNSDuke Royalty at Berenberg UK Corporate Conference
13th Mar 20187:00 amRNSInterim Dividend Increase & Dividend Declaration
8th Mar 20187:00 amRNSDirector/PDMR Shareholdings
6th Mar 20187:00 amRNSLong Term Incentive Plan Awards
5th Mar 20187:00 amRNSNew Royalty Finance Agreement
27th Feb 20187:00 amRNSDuke Royalty Appoints Redleaf Communications
2nd Jan 20184:51 pmRNSHolding(s) in Company
22nd Dec 201712:09 pmRNSHolding(s) in Company
21st Dec 201710:36 amRNSResult of EGM and Issue of Equity
19th Dec 201712:49 pmRNSInterim Dividend
5th Dec 20173:18 pmRNSResult of the Fundraising and Notice of EGM
4th Dec 20174:48 pmRNSProposed Fundraising to raise at least £20 million
13th Nov 20179:39 amRNSFurther Contribution to Royalty Partner
8th Nov 20177:05 amRNSUnaudited Interim Results
8th Nov 20177:00 amRNSStrategic Advisory Agreement
9th Oct 201711:01 amRNSDirector/PDMR Shareholding
6th Oct 20177:00 amRNSNew Royalty Finance Agreement
28th Sep 20172:47 pmRNSBoard changes and investment team addition
27th Sep 201711:46 amRNSResult of AGM
21st Sep 20173:14 pmRNSHolding(s) in Company
21st Sep 20177:00 amRNSChange of Adviser and Interim Dividend
22nd Jun 20173:19 pmRNSFinal Results and Maiden Dividend
22nd Jun 20177:00 amRNSFinal Results
9th Jun 20177:00 amRNSRoyalty Partner Operational Update
6th Apr 20177:00 amRNSInaugural royalty financing agreement
28th Mar 20177:00 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.